These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9431693

  • 1. Fetal fibronectin in patients at increased risk for premature birth.
    Vĕtr M, Kudela M, Prásilová J.
    Acta Univ Palacki Olomuc Fac Med; 1996; 140():55-7. PubMed ID: 9431693
    [Abstract] [Full Text] [Related]

  • 2. [Rational use of fetal fibronectin in the evaluation of premature labor risk].
    Rozenberg P, Nisand I, Malagrida L, Vayssière C, Goffinet F, Philippe HJ, Tribalat S, Giudicelli Y.
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):288-93. PubMed ID: 8767228
    [Abstract] [Full Text] [Related]

  • 3. Cervico-vaginal fetal fibronectin: predictive value during false labor.
    Langer B, Boudier E, Schlaeder G.
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):218-21. PubMed ID: 9093134
    [Abstract] [Full Text] [Related]

  • 4. Performance of cervicovaginal fetal fibronectin in a community hospital setting.
    Incerti M, Ghidini A, Korker V, Pezzullo JC.
    Arch Gynecol Obstet; 2007 May; 275(5):347-51. PubMed ID: 17051404
    [Abstract] [Full Text] [Related]

  • 5. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L.
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [Abstract] [Full Text] [Related]

  • 6. [Is fetal fibronectin a valid test predictive of premature labor?].
    Mansouri A, Tadjerouni A, El Rabiey G, Baube S, Garnier G, Tribalat S.
    Contracept Fertil Sex; 1997 May; 25(5):380-4. PubMed ID: 9273109
    [Abstract] [Full Text] [Related]

  • 7. Assessment of rapid fetal fibronectin in predicting preterm delivery.
    Tekesin I, Marek S, Hellmeyer L, Reitz D, Schmidt S.
    Obstet Gynecol; 2005 Feb; 105(2):280-4. PubMed ID: 15684152
    [Abstract] [Full Text] [Related]

  • 8. [Fetal fibronectin and cervical length as early predictors of preterm labor].
    López Farfán JA, Sánchez Tovar HB, Gutiérrez de Anda Mdel R, Gámez Guevara C.
    Ginecol Obstet Mex; 2011 Jun; 79(6):337-43. PubMed ID: 21966824
    [Abstract] [Full Text] [Related]

  • 9. [Predictive value of cervical-vaginal prolactin in the evaluation of premature labor risk].
    Jotterand AD, Caubel P, Guillaumin D, Augereau F, Chitrit Y, Boulanger MC.
    J Gynecol Obstet Biol Reprod (Paris); 1997 Jun; 26(1):95-9. PubMed ID: 9091552
    [Abstract] [Full Text] [Related]

  • 10. Pregnancy outcome in women with preterm labor symptoms without cervical change.
    Rinehart BK, Terrone DA, Isler CM, Barrilleaux PS, Bufkin L, Morrison JC.
    Am J Obstet Gynecol; 2001 Apr; 184(5):1004-7. PubMed ID: 11303212
    [Abstract] [Full Text] [Related]

  • 11. Fetal fibronectin test predicts delivery before 30 weeks of gestation in high risk women, but increases anxiety.
    Shennan A, Jones G, Hawken J, Crawshaw S, Judah J, Senior V, Marteau T, Chinn S, Poston L.
    BJOG; 2005 Mar; 112(3):293-8. PubMed ID: 15713142
    [Abstract] [Full Text] [Related]

  • 12. Fetal fibronectin as a predictor of preterm birth: an overview.
    Revah A, Hannah ME, Sue-A-Quan AK.
    Am J Perinatol; 1998 Mar; 15(11):613-21. PubMed ID: 10064202
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions.
    Mateus J, Pereira L, Baxter J, Berghella V, Tolosa J.
    Am J Perinatol; 2007 Jun; 24(6):381-5. PubMed ID: 17566945
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery.
    Kekki M, Kurki T, Kärkkäinen T, Hiilesmaa V, Paavonen J, Rutanen EM.
    Acta Obstet Gynecol Scand; 2001 Jun; 80(6):546-51. PubMed ID: 11380291
    [Abstract] [Full Text] [Related]

  • 15. "Blind" vaginal fetal fibronectin as a predictor of spontaneous preterm delivery.
    Roman AS, Koklanaris N, Paidas MJ, Mulholland J, Levitz M, Rebarber A.
    Obstet Gynecol; 2005 Feb; 105(2):285-9. PubMed ID: 15684153
    [Abstract] [Full Text] [Related]

  • 16. Clinical utility of fetal fibronectin for predicting preterm birth.
    Swamy GK, Simhan HN, Gammill HS, Heine RP.
    J Reprod Med; 2005 Nov; 50(11):851-6. PubMed ID: 16419634
    [Abstract] [Full Text] [Related]

  • 17. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J, Chedraui P, Hidalgo L, Medina M.
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [Abstract] [Full Text] [Related]

  • 18. Mammary stimulation test predicts preterm birth in nulliparous women.
    Guinn DA, Wigton TR, James JA, Dunlop DD, Socol M, Frederiksen MC.
    Am J Obstet Gynecol; 1994 Jun; 170(6):1809-12; discussion 1812-4. PubMed ID: 8203442
    [Abstract] [Full Text] [Related]

  • 19. [Prediction of prematurity by oncofetal fibronectin. Prospective cohort study].
    Irion O, Matute J, Bischof P.
    J Gynecol Obstet Biol Reprod (Paris); 1995 Jun; 24(6):624-9. PubMed ID: 8830085
    [Abstract] [Full Text] [Related]

  • 20. Fetal fibronectin in patients at increased risk for premature birth.
    Nageotte MP, Casal D, Senyei AE.
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):20-5. PubMed ID: 8296822
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.